# Merida Biosciences funding rounds and investors

As of 14 Oct 2026, Merida Biosciences has raised $121M across 1 verified round on record; latest: $121 million Series A led by Bain Capital Life Sciences, BVF Partners and 1 other, announced 8 Apr 2025.

Merida Biosciences develops precision therapies for autoimmune-driven diseases targeting pathogenic drivers of antibody-driven diseases.

Website: https://meridabio.com  
Page: https://fireround.dev/companies/meridabio.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-04-08 | Series A | $121 million | Bain Capital Life Sciences, BVF Partners, Third Rock Ventures | GV (Google Ventures), Perceptive Xontogeny Venture Funds (PXV Funds) | [meridabio.com](https://meridabio.com/news/merida-biosciences-launches-with-121m-to-create-therapeutics-for-multiple-autoimmune-and-allergic-diseases), [businesswire.com](https://www.businesswire.com/news/home/20250408215617/en/Merida-Biosciences-Launches-with-%24121M-to-Create-Therapeutics-for-Multiple-Autoimmune-and-Allergic-Diseases) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.